Metraipolis › archive › dc_3817a8302fc2

Integrated plasma proteomics identifies HLA-G and osteopontin as circulating biomarkers of resistance to PD-1 inhibitor plus chemotherapy in choriocarcinoma — Europe PMC PMID:42614392

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42614392
DOI
10.3389/fimmu.2026.1817862
License (as archived)
solo-consultazione
Archived
2026-10-17T04:27:16.810Z
SHA-256 of the archived text
18f648e684cbad4a5fb23d7cb06c5f1a48742fe5989d0a1c4f8bbba8346c961c
Stable URL of this page
https://metraipolis.com/documento/dc_3817a8302fc2

How to cite

Integrated plasma proteomics identifies HLA-G and osteopontin as circulating biomarkers of resistance to PD-1 inhibitor plus chemotherapy in choriocarcinoma — Europe PMC PMID:42614392 — Europe PMC (en), https://europepmc.org/article/MED/42614392 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_3817a8302fc2 (Metraipolis archive dc_3817a8302fc2, sha256 18f648e684cbad4a5fb23d7cb06c5f1a48742fe5989d0a1c4f8bbba8346c961c)
BibTeX
@misc{dc3817a8302fc2,
  title = {Integrated plasma proteomics identifies HLA-G and osteopontin as circulating biomarkers of resistance to PD-1 inhibitor plus chemotherapy in choriocarcinoma — Europe PMC PMID:42614392},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42614392},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_3817a8302fc2; sha256 18f648e684cbad4a5fb23d7cb06c5f1a48742fe5989d0a1c4f8bbba8346c961c},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42614392. Agents can read the archived copy with the MCP tool read_document.